Zoledronic Acid Monohydrate CAS 165800-06-6 Maʻemaʻe ≥99.0% API Factory Maʻemaʻe Kiʻekiʻe
Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: Zoledronic Acid Monohydrate
CAS: 165800-06-6
ʻO kahi bisphosphonate ikaika loa a me ka mea hoʻoulu o PKC
API no ke kūlana kiʻekiʻe, hana kālepa
Inoa Kimia | ʻO Zoledronic Acid Monohydrate |
Helu CAS | 165800-06-6 |
Helu CAT | RF-API56 |
Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
ʻĀpana Molekala | C5H12N2O8P2 |
Kaumaha Molecular | 290.1 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Pauda keʻokeʻo a ʻaneʻane kristal |
ʻIkepili | IR Spectrum;HPLC ChromatogramUV-Vis: Loaʻa ka nui o ka absorbance ma 210nm |
pH | 2.0~4.0 |
Ka hikiwawe | Hiki ke hoʻoheheʻe ʻia i loko o ka solution 0.1N sodium hydroxide, hiki ke hoʻoheheʻe ʻia i ka wai a me 0.1N hydrochloric acid, hiki ʻole ke hoʻoheheʻe ʻia i ka ethanol. |
Ka malamalama a me ke kala | Pono ka hoʻonā ʻana e akaka a kala ʻole;inā opalescent, ʻaʻole pono e ʻoi aku ka opalescent ma mua o ka hoʻokuʻu ʻia ʻana 1;inā waihoʻoluʻu, ʻaʻole i ʻoi aku ka ikaika ma mua o Y2 |
Hoʻokahi haumia | ≤0.50% |
Huina paumaele | ≤1.0% |
Nalo ma ka maloo | 5.0%~8.0% |
Klorida | ≤0.02% |
Phosphate | ≤0.50% |
Phosphite | ≤0.50% |
Nā Metala Kaumaha | ≤10ppm |
Maemae | ≥99.0% |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | API |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO ka Zoledronic acid monohydrate he bisphosphonate ikaika loa a me ka mea hoʻoulu o PKC. ʻO Zoledronic acid monohydrate he heterocyclic bisphosphonate i manaʻoʻia heʻoi aku ka mana o ka bisphosphonates no ka hoʻopauʻana i ka hoʻonuiʻana i ka iwi a ua hoʻohanaʻia i nā haʻawina osteoporosis.ʻO Zoledronic acid monohydrate he mea hoʻopaneʻe o ASM a me FDPS a he mea hoʻoikaika o PKC.ʻO ka Zoledronic acid (zoledronate) he mea hoʻopaneʻe iwi bisphosphonate, he mea hoʻopaneʻe o farnesyl diphosphate (FPP) synthase e hopena i ka hoʻohaʻahaʻa i ka hana osteoclast a hoʻemi i ka resorption iwi a me ka huli ʻana.Ua hoʻohana ʻia no ka mālama ʻana i ka osteoporosis postmenopausal, ka maʻi o Paget, hypercalcemia, a me ka chemotherapy no ka mālama ʻana i ka pōʻino iwi ma muli o ka maʻi kanesa i laha i nā iwi.